Literature DB >> 22364209

Intimate partner violence among HIV-infected crack cocaine users.

Ameeta S Kalokhe1, Anuradha Paranjape, Christine E Bell, Gabriel A Cardenas, Tamy Kuper, Lisa R Metsch, Carlos del Rio.   

Abstract

HIV-infected crack cocaine users are at high risk for HIV transmission and disease progression because they encounter difficulty practicing safe sex, entering and remaining in HIV care, and taking antiretroviral therapy (ART). We hypothesized intimate partner violence (IPV) occurs frequently in this population and contributes to these shortcomings. From December 2006 to April 2010 inpatient HIV-infected crack users were recruited from Grady Memorial (Atlanta, GA) and Jackson Memorial Hospitals (Miami, FL). Participants were screened for IPV using a 5-item tool that was adapted from a previously validated instrument, the STaT. IPV survivors were questioned about support service utilization. Multivariable analysis was conducted to evaluate the association between IPV and unprotected sexual intercourse and sexually transmitted infection (STI) diagnosis in the prior 6 months, use of outpatient HIV care in the past year, and current ART use. We enrolled 343 participants, the majority African Americans of low socioeconomic status. The estimated IPV prevalence was 56%, highest in women (68%) and gay, bisexual, and transgendered men (71%). In multivariable analysis, IPV was associated with diminished ART use (adjusted prevalence ratios [adjPRs] 0.57; 95% confidence interval [CI] 0.41-0.80), unprotected sexual intercourse (adjPR 1.34; 95% CI 1.08-1.68) and STI diagnosis in the prior 6 months (adjPR 3.49; 95% CI 1.60-7.62). After experiencing abuse, IPV survivors most commonly turned to emergency services; however, 38% reported not using any supportive services. This study highlights that IPV occurs frequently among HIV-infected crack users and is associated with outcomes known to facilitate HIV transmission and disease progression. Reduced utilization of outpatient HIV care, ART nonadherence, and new STI diagnoses in this population should trigger IPV screening and support services referral.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364209      PMCID: PMC3317393          DOI: 10.1089/apc.2011.0275

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  26 in total

1.  STaT: a three-question screen for intimate partner violence.

Authors:  Anuradha Paranjape; Jane Liebschutz
Journal:  J Womens Health (Larchmt)       Date:  2003-04       Impact factor: 2.681

2.  Phenomenographic study of women's experiences of domestic violence during the childbearing years.

Authors:  Heather McCosker; Alan Barnard; Rod Gerber
Journal:  Online J Issues Nurs       Date:  2004-01-31

3.  HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities.

Authors:  A H Kral; R N Bluthenthal; R E Booth; J K Watters
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

4.  High prevalence of substance use among heterosexuals living in communities with high rates of AIDS and poverty in Washington, DC.

Authors:  Irene Kuo; Alan E Greenberg; Manya Magnus; Gregory Phillips; Anthony Rawls; James Peterson; Flora Hamilton; Tiffany West-Ojo; Shannon Hader
Journal:  Drug Alcohol Depend       Date:  2011-02-12       Impact factor: 4.492

5.  Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.

Authors:  Margaret R Weeks; Katie E Mosack; Maryann Abbott; Laurie Novick Sylla; Barbara Valdes; Mary Prince
Journal:  Sex Transm Dis       Date:  2004-11       Impact factor: 2.830

6.  Screening for intimate partner violence by health care providers. Barriers and interventions.

Authors:  J Waalen; M M Goodwin; A M Spitz; R Petersen; L E Saltzman
Journal:  Am J Prev Med       Date:  2000-11       Impact factor: 5.043

7.  Intimate partner violence and substance abuse among minority women receiving care from an inner-city emergency department.

Authors:  Nabila El-Bassel; Louisa Gilbert; Susan Witte; Elwin Wu; Theodore Gaeta; Robert Schilling; Takeshi Wada
Journal:  Womens Health Issues       Date:  2003 Jan-Feb

8.  Predicting physical abuse against pregnant Hispanic women.

Authors:  J McFarlane; W Wiist; M Watson
Journal:  Am J Prev Med       Date:  1998-08       Impact factor: 5.043

9.  The role of sexual transmission of HIV infection among injection and non-injection drug users.

Authors:  Steffanie A Strathdee; Susan G Sherman
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

10.  Nine years after child sexual abuse.

Authors:  Heather Y Swanston; Angela M Plunkett; Brian I O'Toole; Sandra Shrimpton; Patrick N Parkinson; R Kim Oates
Journal:  Child Abuse Negl       Date:  2003-08
View more
  18 in total

1.  Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.

Authors:  Sannisha Dale; Mardge Cohen; Kathleen Weber; Ruth Cruise; Gwendolyn Kelso; Leslie Brody
Journal:  AIDS Patient Care STDS       Date:  2014-02-25       Impact factor: 5.078

2.  Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

Review 3.  Trauma-Informed HIV Prevention and Treatment.

Authors:  Jessica M Sales; Andrea Swartzendruber; Ashley L Phillips
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

4.  Application of the Consolidated Framework for Implementation Research to Facilitate Delivery of Trauma-Informed HIV Care.

Authors:  Kaitlin N Piper; Lauren L Brown; Ilyssa Tamler; Ameeta S Kalokhe; Jessica M Sales
Journal:  Ethn Dis       Date:  2021-01-21       Impact factor: 1.847

5.  Intimate Partner Violence Among Female Sex Workers and Their Noncommercial Male Partners in Mexico: A Mixed-Methods Study.

Authors:  Monica D Ulibarri; Marissa Salazar; Jennifer L Syvertsen; Angela R Bazzi; M Gudelia Rangel; Hugo Staines Orozco; Steffanie A Strathdee
Journal:  Violence Against Women       Date:  2018-08-29

6.  High Levels of Syndemics and Their Association with Adherence, Viral Non-suppression, and Biobehavioral Transmission Risk in Miami, a U.S. City with an HIV/AIDS Epidemic.

Authors:  Tiffany R Glynn; Steven A Safren; Adam W Carrico; Noelle A Mendez; Lunthita M Duthely; Sannisha K Dale; Deborah L Jones; Daniel J Feaster; Allan E Rodriguez
Journal:  AIDS Behav       Date:  2019-11

7.  Initial abstinence status and contingency management treatment outcomes: does race matter?

Authors:  LaTrice Montgomery; Kathleen M Carroll; Nancy M Petry
Journal:  J Consult Clin Psychol       Date:  2015-03-23

8.  HIV Treatment for Alcohol and Non-Injection Drug Users in El Salvador.

Authors:  Julia Dickson-Gomez; Gloria Bodnar; Andy Petroll; Kali Johnson; Laura Glasman
Journal:  Qual Health Res       Date:  2015-01-16

9.  "Amar te Duele" ("love hurts"): sexual relationship power, intimate partner violence, depression symptoms and HIV risk among female sex workers who use drugs and their non-commercial, steady partners in Mexico.

Authors:  Monica D Ulibarri; Scott Roesch; M Gudelia Rangel; Hugo Staines; Hortensia Amaro; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2015-01

Review 10.  Intimate partner violence and HIV: a review.

Authors:  Reed A C Siemieniuk; Hartmut B Krentz; M John Gill
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.